Nice one. Glad you're happy with your investment.
No, I don't think the permits are a roadblock at all. Please re-read my posts if that's what you've taken out of it. I never said they weren't going to obtain the approvals - I did however predict they were going to take 6-12 months longer than the stated estimates that management here had said - which I am correct.
Also reading the Allkem annual report and seeing all the work and expansions they're also doing in the area, the Argentinian Government would definitely be giving them priority, as well as from memory another giant (Chinese I think?) company was soon to be investing billions into their Country for lithium mining, which again the Govnmnt would be silly not to prioritise them over AGY.
This could be an explanation for the long winded road to getting expansion approvals over the line.
Also, not directed at you, but because I brought up Allkem again - someone else here said I was 'shilling' that stock. I have no financial interest in Allkem at all. I'm simply bringing them up as they are perfect to compare the scale of the two companies for the purpose of estimating a realistic market cap.
- Forums
- ASX - By Stock
- AGY
- AGY LOM Equivalent
AGY LOM Equivalent, page-108
-
- There are more pages in this discussion • 207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 0.085 |
3 | 99873 | 0.084 |
4 | 169062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 93664 | 1 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
0.091 | 52101 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online